English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Samborska I.A., Maievskyi O.Y. Ahafonov K.M., Kovalchuk O.I.

    ULTRASTRUCTURAL CHANGES IN THE LUNGS OF 1-2 MONTHS-OLD RATS IN THE CONDITIONS OF HYPERHOMOCYSTEINEMIA


    About the author: Samborska I.A., Maievskyi O.Y. Ahafonov K.M., Kovalchuk O.I.
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation A detailed electron microscopic study on structural components in the lungs of 1-2 months-old rats under the conditions of hyperhomocysteinemia was performed. Experiments were performed on 64 white nonlinear male rats. Attention is drawn to the presence of large amount of fibrin and erythrocytes in the lumen of the alveoli surrounded by an electron-dense substrate, which is similar to the blood plasma consistency, which is obviously due to the surfactant film thinning in the alveoli and the increase in fluid transduction from the capillaries placed in the interalveolar septum. Specific features of the study were the presence of transudate in the alveolar space containing blood plasma proteins and fibrin fibers, sludge phenomenon, which prevented blood flow and edema of respiratory alveolocytes. In young animals, changes occur in the blood-air barrier. They are associated with endothelial dysfunction, which in turn is due to local endothelial cells desquamation, changes in the structure of the basement membranes, their loosening, as a result of their layered structure disturbance and obturation of the capillaries’ lumen by the blood formed elements. Damage of the endothelial lining integrity leads to permeation of plasma, fibrin and formed elements into the lumen of the alveoli. The process is accompanied by edema of the respiratory epithelium, which is the result of increased vascular permeability and intravascular pressure.
    Tags homocysteine, hyperhomocysteinemia, lungs, alveolocytes, mitochondria
    Bibliography
    • Voronina LP, Polunina OS, Sevostyanova IV, Polunina VA, Folchari RA, Polunin IN. Gomotsistein i funktsionalnoye sostoyaniye sosudistogo endoteliya pri bronkhialnoy astme. Astrakhanskiy meditsinsiy zhurnal. 2013; 8 (2): 36-38. [in Russian]
    • Horalskyi LP, KhomychVT, Kononskyi OI. Osnovy histolohichnoyi tekhniky i morfofunktsionalni metody doslidzhen u normi ta pry patolohiy. Zhytomyr: 2011. 288 s. [in Ukrainian]
    • Zaichko NV, LutsyukMB, Hryhoryeva HO. Gipergomotsysteyinemia: medyko-sotsialni ta farmakolohichni aspekty. Farmatsevtychnyy kuryer. 2012; 9: 30-35. [in Ukrainian]
    • Zapadnyuk IP, Zapadnyuk VI, Zakharia EA, Zapadnyuk BV. Laboratornyye zhivotnyye. Razvedeniye, soderzhaniye, ispolzovaniye v eksperimente. Kyyiv: 1983. 384 s. [in Russian].
    • Zobova DA, Kozlov SA. Rol gomotsisteina v patogeneze nekotorykh zabolevaniy. Meditsinskiye nauki. 2016; 3 (39): 132-144. [in Russian]
    • Kaur R, Sekhon BS. Hyperhomocysteinemia: An overviews. Ann Pharmacother. 2013; 4: 1-11.
    • Kozhemyakin YM. Naukovo-praktychni rekomendatsiyi z utrymannya laboratornykh tvaryn ta roboty z nymy. Kyyiv: 2002. 156 s. [in Ukrainian]
    • Medvedev DV, Zvyagina VI, Fomina MA. Sposob modelirovaniya tyazheloy formy gipergomotsisteinemii u krys. Rossiyskiy medico-biologicheskiy vestnik imeni akademika I. P. Pavlova. 2014; 4: 42-46. [in Russian]
    • Medvedev DV, Zvyagina VI, Uryasyev OM, Belskikh ES, Bulatetskiy SV, Ryabkov AV. Metabolicheskiye izmeneniya v mitokhondriyakh legkikh pri eksperimentalnoy gipergomotsisteinemii u krys. Biomeditsinskaya khimiya. 2017; 63 (3): 248-254. [in Russian]
    • Mykhaloyko OY. Kontsentratsiyni zminy plazmovoho gomotsysteinu pry hostromu ishemichnomu insulti. Bukovynskyy medychnyy visnyk. 2016; 20, 1 (77): 84-86. [in Ukrainian]
    • Skovierova H, Vidomanova E, Mahmood S, Sopkova J, Drgova A, Cervenova T, et al. The molecular and cellular effect of homocysteine metabolism imbalance on human health. Int J Mol Sci. 2016; 17 (10): 1-18.
    • Yang F, Qi X, Gao Z, Yang X, Zheng X, Duan C, et al. Homocysteine injures endothelial cells by inhibiting mitochondrial activity. Exp Ther Med. 2016; 12 (4): 2247-2252.
    Publication of the article «World of Medicine and Biology» №1(71), 2020 year, 214-217 pages, index UDK 616.24:616.153.478.6
    DOI 10.26724/2079-8334-2020-1-71-214-217